HuGE Literature Finder
|
||
Records 1-11
|
Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association.
Clinical medicine & research 2013 Feb 11 (1): 16-25. Glurich Ingrid, Chyou Po-Huang, Engel Jessica M, Cross Deanna S, Onitilo Adedayo |
|
Estrogen receptor polymorphisms and the vascular effects of hormone therapy.
Arteriosclerosis, thrombosis, and vascular biology 2011 Feb 31 (2): 464-9. Rossouw Jacques, Bray Paul, Liu Jingmin, Kooperberg Charles, Hsia Judith, Lewis Cora, Cushman Mary, Bonds Denise, Hendrix Susan, Papanicolaou George, Howard Timothy, Herrington Dav |
|
Clinical factors such as B-type natriuretic peptide link to factor VII, endothelial NO synthase and estrogen receptor alpha polymorphism in elderly women.
Life sciences 2009 Aug 85 (7-8): 316-21. Funami Jun, Hayashi Toshio, Nomura Hideki, Ding Qun-Fang, Ishitsuka-Watanabe Asako, Matsui-Hirai Hisako, Ina Koichiro, Zhang Jie, Yu Ze-Yun, Iguchi Akihi |
|
Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy.
Breast cancer research and treatment 2009 Jun 115 (3): 643-50. Onitilo Adedayo A, McCarty Catherine A, Wilke Russell A, Glurich Ingrid, Engel Jessica M, Flockhart David A, Nguyen Anne, Li Lang, Mi Deming, Skaar Todd C, Jin Y |
|
A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2008 May 111 (9): 4496-9. French Deborah, Hamilton Leo H, Mattano Leonard A, Sather Harland N, Devidas Meenakshi, Nachman James B, Relling Mary V, |
|
Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.
Circulation 2007 Feb 115 (7): 861-71. Kjaergaard Alisa D, Ellervik Christina, Tybjaerg-Hansen Anne, Axelsson Christen Kirk, Grønholdt Marie-Louise M, Grande Peer, Jensen Gorm B, Nordestgaard Børge |
|
Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis.
Thrombosis research 2007 120 (5): 639-45. Aléssio Aline Morandi, Höehr Nelci Fenalti, Siqueira Lúcia Helena, Ozelo Margareth Castro, de Pádua Mansur Antônio, Annichino-Bizzacchi Joyce Mar |
|
Estrogen receptor alpha polymorphism and venous thromboembolism in male and female: data from the EDITH study.
Thrombosis research 2007 119 (4): 433-9. Oger Emmanuel, Lacut Karine, Mercier Bernard, Le Gal Grégoire, Leroyer Christophe, Pasquier Elisabeth, Férec Claude, Mottier Dominiq |
|
Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosis.
Human reproduction (Oxford, England) 2006 Jun 21 (6): 1473-6. de Maat Moniek P M, Bladbjerg E-M, Kluft C, Winkler U H, Rekers H, Skouby S O, Jespersen |
|
Association of estrogen receptor-alpha genepolymorphisms with venous thrombosis.
Haematologica 2006 Feb 91 (2): 279-80. Lussana Federico, Faioni Elena M, Mavilia Carmelo, Bucciarelli Paolo, Brandi Maria Luisa, Cattaneo Mar |
|
Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study.
Journal of molecular medicine (Berlin, Germany) 2002 Mar 80 (3): 176-80. Lehtimäki Terho, Kunnas Tarja A, Mattila Kari M, Perola Markus, Penttilä Antti, Koivula Timo, Karhunen Pekka |
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: